Post-translational modifications of G protein functions

Basic information

This research project focuses on the activation of a particular protein that has been linked to a large number of human cancers.

Figure 1. G proteins as signaling switches in the cell.

We are focused on elucidating how post-translational modifications contribute to the regulation of G protein function. In particular, we are interested in ubiquitination, the modification of protein substrate with the 8 kDa protein ubiquitin. G proteins, like the protooncogene Ras, are a light-switch-like proteins that regulate signaling pathways that control functions as diverse as cell growth, differentiation, motility, and death (Figure 1). Cancer, which is defined as uncontrolled cell growth, occurs when cells grow or divide in the absence of a signal or ignore signals to stop growing. More than one third of all human cancers are driven by mutations in the small G protein Ras. More specifically, 95% of pancreatic cancers and almost 50% of colorectal cancers contain a Ras mutation.

One modification that Ras has recently been shown to undergo is ubiquitination (Figure 2). Ubiquitination is the process of adding a second protein (ubiquitin) onto Ras. Intriguingly, when ubiquitin is added to Ras, it turns Ras on in the absence of an appropriate signal, leading to unregulated cell growth. Cell growth in the absence of an appropriate signal is a hallmark of cancer. Ubiquitination therefore makes normal Ras look like a mutated form of Ras that causes cancer. Researchers furthermore showed that when a mouse has a tumor with a modification that prevents Ras ubiquitination, the tumor is smaller than a normal tumor. Together, these data suggest that Ras ubiquitination may be important in Ras-driven cancers. The major challenge impeding progress in understanding the role of monoubiquitination in the regulation of Ras in vivo is the challenge of manipulating and observing the small pool of Ras that is modified at a given time in mammalian cells.

Figure 2. Model of Ras (green) modified with the 8 KDa protein Ubiquitin (blue).

Approach

We study post-translational modification of Ras as well as other small G proteins in the yeast (S. cerevisiae) model system. We use in vitro biochemical assays to elucidate mechanisms of regulation and in vivo experiments to understand the impact of these post-translational modifications on signaling. There is a long history of yeast as a source of discovery and innovation, especially in signal transduction. There are tools available in the yeast system that do not exist in other systems. These advantages provide the opportunity to study a process that has clear relevance for health and disease in a model organism, where powerful genetic tools are available.

Studying G protein ubiquitination is technically challenging because there is only a small amount present in mammalian cells at a given time. I previously developed a new method to modify G proteins with ubiquitin in vitro in order to generate enough protein to analyze the effects of ubiquitination (Figure 3). With this technical innovation, it was possible to elucidate the mechanism through which ubiquitination at a particular lysine turns Ras on.

Figure 3. Chemical Linkage of Ubiquitinated Ras. Ubiquitin with a terminal cysteine mutation (G76C) is mixed with Ras under non-reducing conditions. In the presence of an accesible cysteine on Ras (K147C), a disulfide bond forms between the two proteins, mimicking the bond formed when Ras is ubiquitinated in vivo. In the presence of excess Ubiquitin, all Ras is completely modified.

Research Questions

My current research interest is to characterize ubiquitinated yeast Ras using biochemical and cell biological approaches in order to develop a comprehensive picture of Ras regulation by ubiquitination in S. cerevisase. We can approach this question from two directions. First, we will characterize Ras ubiquitination in vivo. Our hypothesis is that ubiquitination activates Ras, similar to what is observed in the mammalian system. We will perform biochemical assays to show if and how Ras is turned on and off when it is ubiquitinated, if ubiquitinated Ras is responsive to regulation, and if the structure changes when Ras is ubiquitinated. We have previously used similar approaches to characterize ubiquitination of mammalian Ras. Second, we will take advantage of yeast genetics and vary how much ubiquitinated Ras is present in the cell at a given time. We can block Ras ubiquitination and determine what impact this has on signaling. In parallel, we can also increase the population of ubiquitinated Ras. Altering the levels of Ras ubiquitination in vivo and looking for changes in signaling output will provide the first direct evidence for the role of ubiquitination in Ras signaling, making it possible to generate a comprehensive understanding of this process. These types of experiments would be prohibitively complex in mammalian cells.

Questions/contact

Rachael Baker

Rachael Baker

Assistant Professor
Full profile

×

  • Course code:
  • Credits:
  • Semester:
  • Department: